4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-127989
Chief Scientific Officer sold 2,856 shares at $28.20 ($80,539)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Beskrovnaya Oxana Chief Scientific Officer | 2024-11-18 | Sale 10b5-1 | −2,856 | $28.20 | $80,539 | 137,519 | D |
| Open-market sales · 2,856 sh · avg $28.20 · $80,539 | |||||||
Loading xslF345X05/ownership.xml…